Bosentan in heart transplantation candidates with severe pulmonary hypertension: Efficacy, safety and outcome after transplantation

Clinical Transplantation

Volumn 27, Issue 1, 2013, Pages 25-31

  Perez Villa, Felix ^a   Farrero, Marta ^a   Cardona, Montse ^a   Castel, Maria Angeles ^a   Tatjer, Irene ^a   Penela, Diego ^a   Vallejos, Isabel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Bosentan; Heart transplantation; Pulmonary hypertension

Indexed keywords

BOSENTAN; CREATININE; DIURETIC AGENT; HEMOGLOBIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FOOT EDEMA; HEART CATHETERIZATION; HEART FAILURE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SIDE EFFECT; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROGNOSIS; SAFETY; SULFONAMIDES;

EID: 84873092344     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01689.x     Document Type: Article

References (22)

1. Stopbierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001: 38: 923.
2. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988: 7: 331.
3. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society of Heart and Lung Transplantation: seventeenth official report - 2000. J Heart Lung Transplant 2000: 19: 909.
4. Stehlik J, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eight adult heart transplant report-2011. J Heart Lung Transplant 2011: 30: 1078.
5. Butler J, Stankewicz MA, Wu J et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 2005: 24: 170.
6. Mehra M, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006: 25: 1024.
7. Elhenawyh AM, Algarni KD, Rodger M et al. Mechanical circulatory support as a bridge to transplant candidacy. J Card Surg 2011: 26: 542.
8. Kirklin JK, Naftel DC, Kormos RL et al. Second INTERMACS annual report: more than 1, 000 primary left ventricular assist device implants. J Heat Lung Transplant 2010: 29: 2.
9. Perez-Villa F, Farrero M, Sionis A, Castel A, Roig E. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension. J Heart Lung Transplant 2010: 29: 817.
10. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high-risk group. J Am Coll Cardiol 1992: 19: 48.
11. Hefke T, Zittermann A, Fuchs U, Schulte-Eistrup S, Gummert JF, Schulz U. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation. Thorac Cardiovasc Surg 2012: 60: 26.
12. Williamson DJ, Walman LL, Jones R et al. Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension. Circulation 2000: 102: 411.
13. Rubin LJ, Badesch DB, Barst RJ et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002: 346: 896.
14. Galiè N, Beghetti M, Gatzoulis MA et al. Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006: 114: 48.
15. Gatzoulis MA, Beghetti M, Galiè N et al. BREATHE-5 Investigators. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol 2008: 127: 27.
16. Monfredi O, Griffiths L, Clarke B, Mahadevan VS. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease. Am J Cardiol 2011: 108: 1483.
17. Galiè N, Hoeper MM, Humbert M et al. ESC Committee for Practice. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009: 30: 2493.
18. Perez-Villa F, Cuppoletti A, Rossel V, Vallejos I, Roig E. Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension. Clin Transplant 2006: 20: 239.
19. Rich S, McLaughlin V. Endothelin receptor blockers in cardiovascular disease. Circulation 2003: 108: 2184.
20. Packer M, McMurray J, Massie B, et al. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Cardiac Fail 2005: 11: 12.
21. Zimpfer D, Zrunek P, Roethy W et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007: 133: 389.
22. Holman WL, Kirklin JK, Naftel DC et al. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg 2010: 139: 1632.